American Society of Nephrology

Todd Alexander, MD, discusses a relatively new field of nephrology research during Kidney Week.

George Bakris, MD, discusses the major study during Kidney Week, as well as what diseases should get more attention in future research.

During Kidney Week, Katherine Tuttle, MD, discusses the plethora of options available to nephrologists, including dulaglutide.

In a study presented at Kidney Week, investigators breakdown data on the end-of-life care for non-dialysis veterans with chronic kidney disease.

Matthew Weir, MD talks about some of the challenges in nephrology and what has people buzzing while at Kidney Week.

Matthew Weir, MD, discusses the START-CKD trial at Kidney Week.

In an abstract presented at Kidney Week, investigators discuss the differences in treatments along different demographical lines.

During Kidney Week, investigators present data showing that canagliflozin could be beneficial for patients across various levels of kidney function.

Investigators from many different fields, including nephrology, oncology, and cardiology, come together to collaborate at Kidney Week.

During Kidney Week, Christine Liu, MD, discusses some of the issues geriatric patients face.

Brad Rovin, MD, discusses the NOBILITY study while at Kidney Week and what its impact on patients with lupus nephritis will be.

Kenneth Mahaffey, MD, discussed during Kidney Week the CREDENCE trial and what the link is between the 3 different medical fields.

Investigators present new data from the OLYMPUS and ROCKIES trials during Kidney Week.

Katja Gist, DO, discusses better ways to prevent acute kidney injuries in pediatric patients who have cardiac surgery.

Brad Rovin, MD, of The Ohio State University, discusses during Kidney Week what is needed for better outcomes for patients with lupus nephritis.

Investigators test a potential treatment for the most common hereditary kidney disease during Kidney Week.